Blood Pressure Drug Recall: Identify if You're Affected

Blood Pressure Drug Recall: Identify if You're Affected

Blood Pressure Drug Recall: Identify if You're Affected

Quick read below — save or share if useful.

More Than 11,000 Bottles of Blood Pressure Drugs Recalled Nationwide for “Cross Contamination”

Roughly 30 million Americans rely on beta-blocker medications to manage high blood pressure or anxiety. However, a recent recall notice issued by the Food and Drug Administration (FDA) has raised concerns about the safety of one particular type of medication due to “cross contamination” during the manufacturing process.

Glenmark Pharmaceuticals Inc., USA, has taken the precautionary measure of recalling the combination blood pressure medication known as Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP. The recall was initiated after routine testing revealed traces of ezetimibe, a cholesterol-lowering medication, in the product. This finding prompted the FDA to classify the recall as a Class III, indicating a low risk of adverse health consequences.

The medication in question, Bisoprolol Fumarate and Hydrochlorothiazide, works by synergistically controlling blood pressure levels. Bisoprolol, a beta-blocker, slows the heart rate and reduces blood pressure, while Hydrochlorothiazide acts as a diuretic to decrease water retention and lower blood pressure. This recall specifically affects 2.5-milligram/6.25-milligram strength tablets packaged in 30-count, 100-count, and 500-count bottles.

It is essential for individuals who take this medication to check the labels of their prescription bottles for the following identifying information:

  • National Drug Codes (NDC):
  • 30-Count: 68462-878-30
  • 100-Count: 68462-878-01
  • 5000-Count: 68462-878-05

Lot Numbers and Expiration Dates:

  • Lot 17232401 — Exp. Date: 11/2025
  • Lot 17240974 — Exp. Date: 05/2026

While the FDA has classified this recall as low-risk, it is crucial for individuals to remain vigilant and seek medical advice if they have any concerns. Pharmaceutical companies face ongoing challenges in maintaining quality control, especially when producing multiple medications in shared facilities. Patients must stay informed and consult healthcare providers if they suspect their prescriptions may be affected.

It is important to note that abruptly discontinuing medication can have adverse effects on certain health conditions. The Mayo Clinic advises against making abrupt changes to your regimen without consulting a healthcare professional. Always follow your doctor’s guidance regarding medication management.

Stay informed about health updates by subscribing to The Healthy newsletter and following The Healthy on Facebook and Instagram. Remember to prioritize your health and well-being by staying informed and proactive about your medication management.

Conclusion

As more than 11,000 bottles of blood pressure medication are recalled nationwide due to cross contamination, it serves as a reminder of the critical importance of quality control in pharmaceutical manufacturing. Patients must remain vigilant, check their medication labels, and consult healthcare providers if they have any concerns about their prescriptions. By staying informed and proactive, individuals can prioritize their health and well-being in today's healthcare landscape.


Follow & Connect
Explore My Other Blogs

Enjoyed this post? Share it or explore more across my blogs and channels.

Comments

Popular Posts